Scarica l'app Stockscreener
6.63
2.07%
-0.14
Dopo l'orario di chiusura:
6.62
-0.010
-0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.77
Aprire:
$6.8
Volume 24 ore:
515.87K
Relative Volume:
1.04
Capitalizzazione di mercato:
$124.41M
Reddito:
$109.43M
Utile/perdita netta:
$5.13M
Rapporto P/E:
25.44
EPS:
0.2606
Flusso di cassa netto:
$18.91M
1 W Prestazione:
+3.59%
1M Prestazione:
+1.07%
6M Prestazione:
-65.40%
1 anno Prestazione:
-31.15%
Intervallo 1D:
$6.46
$6.8923
Intervallo di 1 settimana:
$5.95
$6.99
Portata 52W:
$5.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, BTSG, TEM, HQY, DOCS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.63 | 127.04M | 109.43M | 5.13M | 18.91M | 0.2606 |
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-02-02 | Ripresa | B. Riley Securities | Buy |
| 2022-11-01 | Iniziato | Stifel | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2021-10-18 | Ripresa | B. Riley Securities | Buy |
| 2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
Earnings preview: OptimizeRx Corp. (OPRX) Q1 earnings expected to decline - MSN
OptimizeRx (OPRX) Projected to Post Earnings on Tuesday - MarketBeat
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline - Yahoo Finance
Are Investors Undervaluing OptimizeRx (OPRX) Right Now? - Yahoo Finance
OptimizeRx (OPRX) price target decreased by 40.41% to 14.79 - MSN
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
[ARS] OptimizeRx Corp SEC Filing - Stock Titan
OptimizeRx (OPRX) sets 2026 virtual meeting, equity plan expansion and pay votes - Stock Titan
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report - marketscreener.com
OptimizeRx (OPRX) soars 5.9%: Is further upside left in the stock? - MSN
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4: 30 p.m. ET - marketscreener.com
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 P.m. ET - Moomoo
OPRX OptimizeRx Corporation posts 120.6 percent Q4 2025 EPS surprise, shares rise modestly in today’s trading. - Newser
OptimizeRx (OPRX) Price Target Increased by 24.79% to 24.82 - MSN
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy? - TradingView
JMP Securities Maintains OptimizeRx (OPRX) Market Outperform Recommendation - MSN
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine? - TradingView
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
New OptimizeRx Corp (OPRX) director registers insider status with Form 3 - Stock Titan
Can OptimizeRx's Cash Strength Cushion Near-Term Headwinds? - Yahoo Finance
OptimizeRx Corporation (OPRX) Stock Hits 52-Week High (Weakens) 2026-04-20Institutional Buying - Newser
How The OptimizeRx (OPRX) Narrative Is Shifting As Revenue Caution Meets Profit Optimism - Yahoo Finance
OPRX Trades at a Discount to Industry: How to Approach the Stock Now? - TradingView
Should Value Investors Buy OptimizeRx (OPRX) Stock? - Yahoo Finance
Medical robotics firm Myomo taps ex-OptimizeRx chief for board seat - Stock Titan
OptimizeRx Corp. (NASDAQ:OPRX) Sees Significant Growth in Short Interest - MarketBeat
OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern? - qz.com
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
Whats the profit margin of OptimizeRx Corporation2026 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
OptimizeRx Corp. Receives Favorable Valuation Adjustment Amidst Profit Growth and High Institutional Confidence - Markets Mojo
OptimizeRx Adds Microsoft Health Leader to Board - TipRanks
OptimizeRx adds Microsoft Health exec to board of directors By Investing.com - Investing.com Australia
OptimizeRx adds Microsoft Health exec to board of directors - Investing.com
Microsoft health leader joins OptimizeRx (OPRX) board as independent director - Stock Titan
OptimizeRx Appoints Microsoft Health & Life Sciences COO to Board - National Today
OptimizeRx Appoints Mary Varghese Presti to Board of Directors - Bitget
OptimizeRx Taps Microsoft AI Leader for Board to Supercharge Growth - BriefGlance
Microsoft Health COO joins OptimizeRx board in director refresh - Stock Titan
List of 3 Acquisitions by OptimizeRx (Apr 2026) - Tracxn
Best Value Stocks to Buy for March 16th - Eastern Progress
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - MSN
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.66%
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):